Cargando…
AKR1B1 as a Prognostic Biomarker of High-Grade Serous Ovarian Cancer
SIMPLE SUMMARY: We evaluated the levels of AKR1B1 and AKR1B10 in 99 patients with high-grade serous ovarian cancer and their association with clinicopathological characteristics, survival, and response to chemotherapy. An immunohistochemical analysis showed that higher AKR1B1 levels correlated with...
Autores principales: | Hojnik, Marko, Šuster, Nataša Kenda, Smrkolj, Špela, Sisinger, Damjan, Grazio, Snježana Frković, Verdenik, Ivan, Rižner, Tea Lanišnik |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8834204/ https://www.ncbi.nlm.nih.gov/pubmed/35159076 http://dx.doi.org/10.3390/cancers14030809 |
Ejemplares similares
-
AKR1C3 Is Associated with Better Survival of Patients with Endometrial Carcinomas
por: Hojnik, Marko, et al.
Publicado: (2020) -
AKR1B1 and AKR1B10 as Prognostic Biomarkers of Endometrioid Endometrial Carcinomas
por: Hojnik, Marko, et al.
Publicado: (2021) -
Data on expression of genes involved in estrogen and progesterone action, inflammation and differentiation according to demographic, histopathological and clinical characteristics of endometrial cancer patients
por: Sinreih, Maša, et al.
Publicado: (2017) -
Enzymes of the AKR1B and AKR1C Subfamilies and Uterine Diseases
por: Rižner, Tea Lanišnik
Publicado: (2012) -
The Co-Expression of Estrogen Receptors ERα, ERβ, and GPER in Endometrial Cancer
por: Hojnik, Marko, et al.
Publicado: (2023)